Julia Stephany Lima
Research Subjects
Julia Stephany Lima has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Flávia Sobreira Mendonça Gonçalves
Centro Universitário São Camilo
1 shared publication - Isabela Garcia Vizza1 shared publication
- Michelle Maria Gonçalves Barão de Aguiar
Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil
1 shared publication - Michelli Ferrera Dario
Centro Universitário São Camilo – CUSC. São Paulo/SP, Brasil
1 shared publication - Priscila Alves Balista
Centro Universitário São Camilo – CUSC. São Paulo/SP, Brasil
1 shared publication - Rodrigo Vieira Gonzaga
Universidade de São Paulo
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Research, Society and Development in Research, Society and Development
- Vol. 15 (6)
Development and optimization of a film-forming gel of betamethasone valerate using quality by design approach
Betamethasone valerate was selected as the model corticosteroid due to its well-established anti-inflammatory activity and widespread use in the topical management of inflammatory dermatoses, including psoriasis. However, conventional topical formulations, such as creams, may present limitations. In this context, film-forming systems have emerged as a promising alternative for topical drug delivery. Therefore, this study aimed to develop and optimize a betamethasone valerate-loaded film-forming gel using a Quality by Design (QbD) approach. The optimized formulation was evaluated in terms of drying time, film flexibility, tensile strength, and water vapor permeability. The screening step identified the type of film-forming polymer and the type of volatile vehicle as the main Critical Material Attributes (CMAs). The optimized formulation, containing 12% polyvinyl alcohol (PVA) and 10% ethanol (96% v/v), showed the best overall performance, exhibiting good spreadability, transparency, appropriate drying behavior, and continuous film formation. Mechanical and barrier-related tests indicated behavior consistent with a flexible film and a semi-occlusive profile, supporting the suitability of the formulation as a film-forming gel. These findings demonstrate the technical feasibility of the developed formulation as a topical film-forming system for betamethasone valerate delivery. The optimized gel represents a promising platform for further longitudinal and clinical studies to assess its efficacy and applicability in psoriasis management.
- 1 June 2026
- Published by Research, Society and Development in Research, Society and Development
- Vol. 15 (6)
Open AccessDevelopment and optimization of a film-forming gel of betamethasone valerate using quality by design approach
Betamethasone valerate was selected as the model corticosteroid due to its well-established anti-inflammatory activity and widespread use in the topical management of inflammatory dermatoses, including psoriasis. However, conventional topical formulations, such as creams, may present limitations. In this context, film-forming systems have emerged as a promising alternative for topical drug delivery. Therefore, this study aimed to develop and optimize a betamethasone valerate-loaded film-forming gel using a Quality by Design (QbD) approach. The optimized formulation was evaluated in terms of drying time, film flexibility, tensile strength, and water vapor permeability. The screening step identified the type of film-forming polymer and the type of volatile vehicle as the main Critical Material Attributes (CMAs). The optimized formulation, containing 12% polyvinyl alcohol (PVA) and 10% ethanol (96% v/v), showed the best overall performance, exhibiting good spreadability, transparency, appropriate drying behavior, and continuous film formation. Mechanical and barrier-related tests indicated behavior consistent with a flexible film and a semi-occlusive profile, supporting the suitability of the formulation as a film-forming gel. These findings demonstrate the technical feasibility of the developed formulation as a topical film-forming system for betamethasone valerate delivery. The optimized gel represents a promising platform for further longitudinal and clinical studies to assess its efficacy and applicability in psoriasis management.